SCEMBLIX – Home – MOP Product
Image
SCEMBLIX Home banner MOP.
Image
SCEMBLIX Home Banner mobile.

More information

Summary of Product Characteristics (SmPC) for asciminib Great Britain and Northern Ireland

These links will take you to the electronic medicines compendium (emc) websites, which are non-Novartis websites.

Patient Information Leaflet (PIL) for asciminib Great Britain and Northern Ireland

These links will take you to the electronic medicines compendium (emc) websites, which are non-Novartis websites.

UK | October 2024 | 444956

Reporting side-effects

If you get side-effects with any medication you are taking, talk to your doctor, pharmacist or nurse. This includes any possible side-effects not listed in the information leaflet that comes in the pack. ▼ The medicine referred to in this material is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side-effects you may get. Please see www.mhra.gov.uk/yellowcard. for instructions on how to report side-effects.

Reporting side-effects

If you get side-effects with any medication you are taking, talk to your doctor, pharmacist or nurse. This includes any possible side-effects not listed in the information leaflet that comes in the pack. You can report side-effects via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard.
By reporting side-effects you can help provide more information on the safety of your medication.


Source URL: https://www.pro.novartis.com/uk-en/public/medicines/haematology/scemblix